200020012002200320042005200620072008
Pages:
«<56789>»
NOTICES: National Institute of Child Health and Human Development,
Published: 2008-09-30
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Child Health and Human Development,
Published: 2008-09-30
Pursuant to section 10(d) of the Federal Advisory Committee Act, as [[Page 56852]]
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and
NOTICES: National Institute of Child Health and Human Development,
Published: 2008-09-30
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Diabetes and Digestive and Kidney Diseases,
Published: 2008-09-30
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language
NOTICES: Histone Deacetylase Inhibitors for the Prevention and Treatment of Central Nervous System Metastases of Extra-CNS Origin Cancers,
Published: 2008-09-30
This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR
Part 404.7(a)(1)(i), announces that the Department of Health and Human
Services is contemplating the grant of an exclusive license to practice
the inventions embodied in U.S. Provisional Application 60/891,856
filed February 27, 2007 (E0842007/0US01) and International
Application
NOTICES: Web Location of 2009 Proposed Guidance Development,
Published: 2008-09-30
The Food and Drug Administration (FDA) is announcing the Web
location where the agency will post a list of guidance documents the
Center for Devices and Radiological Health (CDRH) is considering for
development in fiscal year (FY) 2009. In addition, FDA has established
a docket where stakeholders may provide comments and/or draft language
for
NOTICES: Antiviral Drugs Advisory Committee,
Published: 2008-09-30
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public.
Name of Committee: Antiviral Drugs Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 10413), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being
RULES: Reporting Information About Authorized Generic Drugs,
Published: 2008-09-29
The Food and Drug Administration (FDA) is amending its
regulations to require that the holder of a new drug application (NDA)
submit certain information regarding authorized generic drugs in an
annual report. We are taking this action as part of our implementation
of the Food and Drug Administration Amendments Act of 2007 (FDAAA).
FDAAA requires
RULES: Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis,
Published: 2008-09-29
The Food and Drug Administration (FDA) is amending its
labeling regulation authorizing a health claim on the relationship
between calcium and a reduced risk of osteoporosis to include vitamin D
so that, in addition to the claim for calcium and osteoporosis, an
additional claim can be made for calcium and vitamin D and
osteoporosis; eliminate the
PROPOSED RULES: Reporting Information About Authorized Generic Drugs; Companion Document to Direct Final Rule,
Published: 2008-09-29
The Food and Drug Administration (FDA) is publishing this
companion proposed rule to the direct final rule, published elsewhere
in this issue of the Federal Register, which is intended to amend our
regulations to require that the holder of a new drug application (NDA)
submit certain information in an annual report regarding authorized
generic
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: Approval of Det Norske Veritas Healthcare, Inc. for Deeming Authority for Hospitals,
Published: 2008-09-29
This notice announces our decision to approve Det Norske
Veritas Healthcare, Inc. (DNVHC) for recognition as a national
accreditation program for hospitals seeking to participate in the
Medicare or Medicaid programs.
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
Proposed Projects
Title: Child Care and Development Fund Plan for States/Territories for FFY 20102011 (ACF118).
OMB No.: 09700114.
Description: The Child Care and Development Fund (CCDF) Plan (the
Plan) for States and Territories is required from each CCDF Lead agency
in accordance with Section 658E of the Child Care and Development
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
Proposed Projects
Title: Methodology for Determining Whether an Increase in a State's Child Poverty Rate Is the Result of the TANF ProgramNPRM.
OMB No.: 09700186.
Description: In accordance with Section 413(i) of the Social
Security Act and 45 CFR part 284, the Department of Health and Human
Services (HHS) intends to reinstate the
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
Proposed Projects
Title: Protection and Advacacy (P&A) Voting Access Application and Annual Report.
OMB No.: 09700326.
Description: This is a revision to include the application for the
previously cleared Help America Vote Act (HAVA) Annual report.
An application is required by Federal statute (the Help America
Vote Act (HAVA) of
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-09-29
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). To
request a copy of the clearance requests submitted to OMB for review,
email
Part II: Health and Human Services Department, Centers for Medicare & Medicaid Services,
Published: 2008-09-26
This notice lists CMS manual instructions, substantive and
interpretive regulations, and other Federal Register notices that were
published from April 2008 through June 2008, relating to the Medicare
and Medicaid programs. This notice provides information on national
coverage determinations (NCDs) affecting specific medical and health
care
NOTICES: Adjustment to the Amount in Controversy Threshold Amounts for Calendar Year (2009),
Published: 2008-09-26
This notice announces the annual adjustment in the amount in
controversy (AIC) threshold amounts for Administrative Law Judge (ALJ)
hearings and judicial review under the Medicare appeals process. The
adjustment to the AIC threshold amounts will be effective for requests
for ALJ hearings and judicial review filed on or after January 1, 2009.
The
NOTICES: Medicare Evidence Development and Coverage Advisory Committee,
Published: 2008-09-26
This notice announces that a public meeting of the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC)
(``Committee'') will be held on Wednesday, November 19, 2008. The
Committee generally provides advice and recommendations concerning the
adequacy of scientific evidence needed to determine whether certain
medical items and
NOTICES: Medicare Program; Advisory Panel on Medicare Education,
Published: 2008-09-26
In accordance with the Federal Advisory Committee Act, this
notice announces a meeting of Advisory Panel on Medicare Education (the
Panel). The Panel advises and makes recommendations to the Secretary of
Health and Human Services and the Administrator of the Centers for
Medicare & Medicaid Services on the effectiveness of consumer education
NOTICES: Statement of Organization, Functions, and Delegations of Authority,
Published: 2008-09-26
Part F of the Statement of Organization, Functions, and Delegations
of Authority for the Department of Health and Human Services, Centers
for Medicare & Medicaid Services (CMS), (Federal Register, Vol. 73, No.
127, pp. 3746337464, dated Tuesday, July 1, 2008) is amended to
reflect an update to the functions for the Center for Medicare
Part V: Family Support Administration, Child Support Enforcement Office; Health and Human Services Department, Children and Families Administration,
Published: 2008-09-26
The Personal Responsibility and Work Opportunity
Reconciliation Act of 1996 (PRWORA) created and expanded State and Federal title IVD child support enforcement databases and
significantly enhanced access to information for title IVD child
support purposes. States are moving toward integrated service delivery
and developing enterprise architecture
NOTICES: Draft Guidance for Industry on End-of-Phase 2A Meetings; Availability,
Published: 2008-09-26
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``EndofPhase
2A Meetings.'' This draft guidance provides information on endofphase
2A (EOP2A) meetings for sponsors of investigational new drug
applications (INDs) who seek guidance on employing clinical trial
simulation and quantitative
NOTICES: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,
Published: 2008-09-26
The Food and Drug Administration (FDA) is publishing a list of
premarket approval applications (PMAs) that have been approved. This
list is intended to inform the public of the availability of safety and
effectiveness summaries of approved PMAs through the Internet and the
agency's Division of Dockets Management.